These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 35507182)
21. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway. Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039 [TBL] [Abstract][Full Text] [Related]
22. High-Resolution In Situ High-Content Imaging of 3D-Bioprinted Single Breast Cancer Spheroids for Advanced Quantification of Benzo( Hong S; Song JM ACS Appl Mater Interfaces; 2023 Mar; 15(9):11416-11430. PubMed ID: 36812369 [TBL] [Abstract][Full Text] [Related]
23. Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds. Palomeras S; Rabionet M; Ferrer I; Sarrats A; Garcia-Romeu ML; Puig T; Ciurana J Molecules; 2016 Apr; 21(4):537. PubMed ID: 27120585 [TBL] [Abstract][Full Text] [Related]
24. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs. Ji P; Zhang Y; Wang SJ; Ge HL; Zhao GP; Xu YC; Wang Y Oncol Rep; 2016 Jun; 35(6):3293-302. PubMed ID: 27109463 [TBL] [Abstract][Full Text] [Related]
25. Tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties. Liu H; Zhang HW; Sun XF; Guo XH; He YN; Cui SD; Fan QX Chin Med J (Engl); 2013 Aug; 126(16):3030-4. PubMed ID: 23981606 [TBL] [Abstract][Full Text] [Related]
26. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
27. A recombinant protein TmSm(T34A) can inhibit proliferation and proapoptosis to breast cancer stem cells(BCSCs) by down-regulating the expression of Cyclin D1. Ma X; Zhang Y; Kang Y; Li L; Zheng W Biomed Pharmacother; 2016 Dec; 84():373-381. PubMed ID: 27668537 [TBL] [Abstract][Full Text] [Related]
28. In Vitro Assays of Breast Cancer Stem Cells. Samanta D; Semenza GL Methods Mol Biol; 2018; 1742():237-246. PubMed ID: 29330805 [TBL] [Abstract][Full Text] [Related]
29. Suppressive role of Viola odorata extract on malignant characters of mammosphere-derived breast cancer stem cells. Yousefnia S; Naseri D; Seyed Forootan F; Tabatabaeian M; Moattar F; Ghafghazi T; Nasr Esfahani MH; Ghaedi K Clin Transl Oncol; 2020 Sep; 22(9):1619-1634. PubMed ID: 32056127 [TBL] [Abstract][Full Text] [Related]
30. Breast Cancer Spheroids Reveal a Differential Cancer Stem Cell Response to Chemotherapeutic Treatment. Reynolds DS; Tevis KM; Blessing WA; Colson YL; Zaman MH; Grinstaff MW Sci Rep; 2017 Sep; 7(1):10382. PubMed ID: 28871147 [TBL] [Abstract][Full Text] [Related]
31. Isolation of spheroid-forming single cells from gastric cancer cell lines: enrichment of cancer stem-like cells. Lee JW; Sung JS; Park YS; Chung S; Kim YH Biotechniques; 2018 Oct; 65(4):197-203. PubMed ID: 30284938 [TBL] [Abstract][Full Text] [Related]
32. Methyl Antcinate A suppresses the population of cancer stem-like cells in MCF7 human breast cancer cell line. Peng CY; Fong PC; Yu CC; Tsai WC; Tzeng YM; Chang WW Molecules; 2013 Feb; 18(3):2539-48. PubMed ID: 23442930 [TBL] [Abstract][Full Text] [Related]
33. Mammary stem cells and breast cancer--role of Notch signalling. Farnie G; Clarke RB Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349 [TBL] [Abstract][Full Text] [Related]
34. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications. Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295 [TBL] [Abstract][Full Text] [Related]
35. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response. Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099 [TBL] [Abstract][Full Text] [Related]
36. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Nishi M; Sakai Y; Akutsu H; Nagashima Y; Quinn G; Masui S; Kimura H; Perrem K; Umezawa A; Yamamoto N; Lee SW; Ryo A Oncogene; 2014 Jan; 33(5):643-52. PubMed ID: 23318426 [TBL] [Abstract][Full Text] [Related]
37. Polymer Thin Film-Induced Tumor Spheroids Acquire Cancer Stem Cell-like Properties. Choi M; Yu SJ; Choi Y; Lee HR; Lee E; Lee E; Lee Y; Song J; Son JG; Lee TG; Kim JY; Kang S; Baek J; Lee D; Im SG; Jon S Cancer Res; 2018 Dec; 78(24):6890-6902. PubMed ID: 30352813 [TBL] [Abstract][Full Text] [Related]
38. Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound Screening. Goričan L; Gole B; Potočnik U Cells; 2020 Jul; 9(7):. PubMed ID: 32708734 [TBL] [Abstract][Full Text] [Related]
40. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Farnie G; Sotgia F; Lisanti MP Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]